The Lysine Histone Methyltransferase SETD2 Is Required for Appropriate Immunoglobulin VDJ Recombination

被引：0
|
作者：
Chu, S. Haihua [1 ]
Chabon, Jonathan [2 ]
Minehart, Janna [3 ]
Matovina, Chloe N. [2 ]
Zhang, Jian [2 ]
Chen, Bo-Ruei [4 ]
Callen-Moreu, Elsa [5 ]
Hung, Putzer J. [4 ]
Feng, Zhaohui [2 ]
Koche, Richard [6 ]
Liu, X. Shirley [2 ]
Chaudhuri, Jayanta [7 ]
Nussenzweig, Andre [5 ]
Sleckman, Barry [4 ]
Armstrong, Scott A. [2 ]
机构：
[1] Dana Farber Canc Inst, Pediat Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] NYU, Sch Med, New York, NY USA
[4] Weill Cornell Med Coll, New York, NY USA
[5] NCI, NIH, Bethesda, MD 20892 USA
[6] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-111952
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
511
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, T. H.
    Monzon, F. A.
    Hoang, A.
    Hung, M. C.
    Jonasch, E.
    BJU INTERNATIONAL, 2012, 109 : 1 - 2
  • [32] Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies
    Lampe, John W.
    Alford, Joshua S.
    Boriak-Sjodin, P. Ann
    Brach, Dorothy
    Cosmopoulos, Kat
    Duncan, Kenneth W.
    Eckley, Sean T.
    Foley, Megan A.
    Harvey, Darren M.
    Motwani, Vinny
    Munchhof, Michael J.
    Raimondi, Alejandra
    Riera, Thomas, V
    Tang, Cuyue
    Thomenius, Michael J.
    Totman, Jennifer
    Farrow, Neil A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (10): : 1539 - 1545
  • [33] Molecular characterization of SETD2, a histone methyltransferase, in clear cell renal cell carcinoma (ccRCC)
    Thai Huu Ho
    Monzon, Federico A.
    Hoang, Anh
    Tamboli, Pheroze
    Furge, Kyle A.
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar M.
    Hung, Mien-Chie
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Downregulation of the histone methyltransferase SETD2 promotes imatinib resistance in chronic myeloid leukaemia cells
    Sheng, Yaru
    Ji, Zhongzhong
    Zhao, Huifang
    Wang, Jinming
    Cheng, Chaping
    Xu, Weimin
    Wang, Xue
    He, Yuman
    Liu, Kaiyuan
    Li, Li
    Voeltzel, Thibault
    Maguer-Satta, Veronique
    Gao, Wei-Qiang
    Zhu, Helen He
    CELL PROLIFERATION, 2019, 52 (04)
  • [35] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, Thai H.
    Monzon, Federico A.
    Anh Hoang
    Tamboli, Pheroze
    Furge, Kyle
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar
    Jonasch, Eric
    Hung, Mien-Chie
    CANCER RESEARCH, 2012, 72
  • [36] H3K36 Histone Methyltransferase Setd2 Is Required for Murine Embryonic Stem Cell Differentiation toward Endoderm
    Zhang, Yuanliang
    Xie, Shugao
    Zhou, Yan
    Xie, Yinyin
    Liu, Ping
    Sun, Mingming
    Xiao, Huasheng
    Jin, Ying
    Sun, Xiaojian
    Chen, Zhu
    Huang, Qiuhua
    Chen, Saijuan
    CELL REPORTS, 2014, 8 (06): : 1989 - 2002
  • [37] Regulation of SETD2, a histone methyltransferase, in advanced clear cell renal cell carcinoma (ccRCC).
    Thai Huu Ho
    Monzon, Federico A.
    Anh Hoang
    Tamboli, Pheroze
    Furge, Kyle A.
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar M.
    Mien-Chie Hung
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [38] Canine osteosarcoma genome sequencing identifies recurrent mutations in DMD and the histone methyltransferase gene SETD2
    Gardner, Heather L.
    Sivaprakasam, Karthigayini
    Briones, Natalia
    Zismann, Victoria
    Perdigones, Nieves
    Drenner, Kevin
    Facista, Salvatore
    Richholt, Ryan
    Liang, Winnie
    Aldrich, Jessica
    Trent, Jeffrey M.
    Shields, Peter G.
    Robinson, Nicholas
    Johnson, Jeremy
    Lana, Susan
    Houghton, Peter
    Fenger, Joelle
    Lorch, Gwendolen
    Janeway, Katherine A.
    London, Cheryl A.
    Hendricks, William P. D.
    COMMUNICATIONS BIOLOGY, 2019, 2 (1)
  • [39] SetD2 histone methyltransferase mutation status predicts treatment response in glioblastoma: Strategies to overcome chemoresistance
    Gabriel, Nishanth
    Dahiya, Sonika
    Wang, Xiaowei
    Goldstein, Michael
    CANCER RESEARCH, 2020, 80 (16)
  • [40] Chromatin remodeling by the histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction
    Costantino, S.
    Ambrosini, S.
    Mohammed, S. A.
    Gorica, E.
    Ruschitzka, F.
    Paneni, F.
    EUROPEAN HEART JOURNAL, 2024, 45
12345